The Pew Charitable Trusts, together with the American Public Health Association, the Association for Accessible Medicines, the Biotechnology Innovation Organization, and the Pharmaceutical Research and Manufacturers of America, sent a letter to the acting secretary of the Department of Health and Human Services (HHS).
The groups applauded HHS’s significant progress toward implementing the Drug Quality and Security Act of 2013 and creating a clear framework for compounded medicines. As the administration continues to develop the new oversight system, the groups also urged the department to ensure that compounded medications are made under appropriate quality standards by upholding three principles: that a prescription is the line between outsourcing facilities and traditional compounders, that flexibility for outsourcing facilities does not compromise patient safety, and that traditional compounders produce drugs under sanitary conditions.
America’s Overdose Crisis
Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care